Suven Life secures four product patents

19 Aug 2011 Evaluate

Suven Life Sciences has won four product patents for its new chemical entities designed for treatment of neurodegenerative diseases. These were granted in Europe, Sri Lanka and South Korea for compounds that are being developed as therapeutic agents for Alzheimer's disease, Parkinson's and Schizophrenia, among others.

The cognitive disorders for which these drugs would be developed were a $ 30-billion market globally. With this, the biopharma company has a total of 11 granted patents from Europe, eight from Sri Lanka and five from South Korea. These patents are its exclusive intellectual property, achieved through internal research. Products developed out of these inventions may be outlicensed at different phases of clinical development.crackcrack

Suven Life Sciences Share Price

122.40 2.85 (2.38%)
11-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1687.55
Dr. Reddys Lab 1109.15
Cipla 1463.15
Lupin 1969.05
Zydus Lifesciences 868.25
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...